Gina Gurganus

Email : g***@***

Phone - +31***243

Last updated on 10/09/2022

Patheon Pharmaceuticals

Herengracht 483, , Amsterdam,

, Netherlands

Wish to Target Similar Profiles?


September 30, 2014 - Gallus BioPharmaceuticals, LLC has been acquired by DPx Holdings B.V., privately owned by JLL Partners and Royal DSM and the parent company of Patheon. Patheon’s biologic drug substance business, a unit of DPx Holdings, now spans four global facilities in Europe, Australia and N...

Industry : Biotechnology

Products and Services : Cell Line Optimization,Upstream & Downstream Process Development,Drug Substance Manufacturing,Bioreactor Production from 20 to 2,000L,Purification at Scale,Protein Modification and Conjugation,Formulation and Aseptic Filling,cGMP,Single-Use Technologies

Revenues (in million) : $ 1900.0000

Employees : 201-500

* If this information is incorrect or inaccurate, please email us at

* If you have any issues with the data displayed here, please email us at

Key People

Ken Wilmot

Executive title(s): IT Director - UK and Global SAP

Email Phone

Patheon Pharmaceuticals

Daniel Petrovich

Executive title(s): Senior QA & QC Manager

Email Phone

Patheon Pharmaceuticals

Similar Companies

Agilent Technologies

Fluidigm Corporation

PTC Therapeutics, Inc.